$0.47 EPS Expected for Merit Medical Systems, Inc. (NASDAQ:MMSI) This Quarter

Analysts predict that Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Rating) will report earnings of $0.47 per share for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Merit Medical Systems’ earnings. The highest EPS estimate is $0.48 and the lowest is $0.45. Merit Medical Systems reported earnings per share of $0.52 in the same quarter last year, which would suggest a negative year-over-year growth rate of 9.6%. The company is expected to issue its next earnings report on Monday, January 1st.

On average, analysts expect that Merit Medical Systems will report full-year earnings of $2.49 per share for the current financial year, with EPS estimates ranging from $2.44 to $2.55. For the next financial year, analysts anticipate that the firm will report earnings of $2.78 per share, with EPS estimates ranging from $2.70 to $2.85. Zacks’ EPS averages are a mean average based on a survey of sell-side analysts that follow Merit Medical Systems.

Merit Medical Systems (NASDAQ:MMSI – Get Rating) last released its quarterly earnings data on Thursday, February 24th. The medical instruments supplier reported $0.71 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.50 by $0.21. Merit Medical Systems had a return on equity of 13.54% and a net margin of 4.51%. The business had revenue of $278.50 million for the quarter, compared to analysts’ expectations of $270.96 million. During the same quarter in the previous year, the business posted $0.54 EPS. Merit Medical Systems’s revenue for the quarter was up 7.9% on a year-over-year basis.

MMSI has been the subject of several research analyst reports. StockNews.com lowered Merit Medical Systems from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, April 5th. Piper Sandler decreased their price objective on Merit Medical Systems from $79.00 to $75.00 in a research report on Friday, February 25th. TheStreet upgraded Merit Medical Systems from a “c” rating to a “b-” rating in a research report on Friday, February 25th. Needham & Company LLC reduced their price target on Merit Medical Systems from $83.00 to $73.00 and set a “buy” rating for the company in a research report on Friday, February 25th. Finally, Raymond James reduced their price target on Merit Medical Systems from $73.00 to $72.00 and set an “outperform” rating for the company in a research report on Friday, February 25th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $75.20.

Large investors have recently added to or reduced their stakes in the business. BNP Paribas Arbitrage SA boosted its position in Merit Medical Systems by 181.8% during the 3rd quarter. BNP Paribas Arbitrage SA now owns 49,055 shares of the medical instruments supplier’s stock worth $3,522,000 after acquiring an additional 31,650 shares during the last quarter. Emerald Mutual Fund Advisers Trust raised its stake in shares of Merit Medical Systems by 22.5% during the 3rd quarter. Emerald Mutual Fund Advisers Trust now owns 472,218 shares of the medical instruments supplier’s stock worth $33,905,000 after purchasing an additional 86,729 shares in the last quarter. FDx Advisors Inc. raised its stake in shares of Merit Medical Systems by 15.2% during the 4th quarter. FDx Advisors Inc. now owns 7,919 shares of the medical instruments supplier’s stock worth $493,000 after purchasing an additional 1,043 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of Merit Medical Systems by 8.8% during the 3rd quarter. Bank of New York Mellon Corp now owns 587,833 shares of the medical instruments supplier’s stock worth $42,206,000 after purchasing an additional 47,320 shares in the last quarter. Finally, Strs Ohio raised its stake in shares of Merit Medical Systems by 7.1% during the 4th quarter. Strs Ohio now owns 22,700 shares of the medical instruments supplier’s stock worth $1,414,000 after purchasing an additional 1,500 shares in the last quarter. 95.93% of the stock is owned by hedge funds and other institutional investors.

Shares of MMSI traded down $0.60 on Wednesday, hitting $67.41. The company’s stock had a trading volume of 8,414 shares, compared to its average volume of 350,413. The company has a quick ratio of 1.10, a current ratio of 2.04 and a debt-to-equity ratio of 0.23. The firm’s fifty day moving average price is $61.89 and its 200-day moving average price is $63.99. Merit Medical Systems has a fifty-two week low of $51.66 and a fifty-two week high of $73.85. The firm has a market capitalization of $3.81 billion, a price-to-earnings ratio of 79.60, a P/E/G ratio of 2.60 and a beta of 1.03.

About Merit Medical Systems (Get Rating)

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.

Featured Articles